Industry / Bosnia-Herzegovina
Bosnalijek Expands Overseas
January 2008 | Industry NewsBosnian pharmaceutical firm Bosnalijek is expecting sales in 2007 to be 20% higher than in 2006, according to general manager Edin Arslanagic. The firm posted revenues of BAM88mn (US$66.9mn) in 2006, but since then it has expanded into a number of emerging markets, such as Kazakhstan, Azerbaijan, Algeria and Cameroon.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
